Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine inhibition of THC-induced psychotomimetic effects
NL-OMON33219Active, not recruiting
- Sponsor
- Centre for Human Drug Research
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of olanzapine, dronabinol and diphenhydramine in Schizophrenia Spectrum Disorders (SSD) (5 arms), sponsored by Centre for Human Drug Research. Primary endpoints: Positive and Negative Syndrome Scale and Visual Analogue Scales. Started Apr 2009; status: active, not recruiting.
02
Drugs
olanzapinedronabinoldiphenhydramine
03
Conditions
Schizophrenia Spectrum Disorders (SSD)
Beyond the preview
Go deeper on NL-OMON33219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33219.